National Institute of Pediatrics, Mexico
12
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
42%
5 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with Leukemia
Role: lead
Shehata Technique in the Treatment of Intra-abdominal Testis
Role: lead
Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy
Role: collaborator
Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial
Role: collaborator
Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.
Role: lead
Acute Abdomen in Kawasaki Disease
Role: lead
Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs
Role: lead
Montelukast and Loratadine in Children With Asthma
Role: collaborator
Characterization of Influenza-like Illness in Mexico
Role: collaborator
A Prebiotic Agave Derivated Metlin & Metlos in Infant Formula
Role: lead
Lactobacillus Reuteri DSM 17938 and Prevention of Respiratory and Gastrointestinal Infections in Mexican Infants
Role: lead
Safety, Efficacy and Cost-effectiveness of Racecadotril in Children With Acute Diarrhea in Mexico
Role: lead
All 12 trials loaded